These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17922587)

  • 1. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
    Folpe AL; Cooper K
    Arch Pathol Lab Med; 2007 Oct; 131(10):1517-24. PubMed ID: 17922587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
    Dotto J; Glusac E
    Arch Pathol Lab Med; 2008 May; 132(5):732. PubMed ID: 18466010
    [No Abstract]   [Full Text] [Related]  

  • 4. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction and clarification regarding AFX and pleomorphic dermal sarcoma.
    McCalmont TH
    J Cutan Pathol; 2012 Jan; 39(1):8. PubMed ID: 22211329
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
    Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
    J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red is dead.
    McCalmont TH
    J Cutan Pathol; 2012 Mar; 39(3):315-6. PubMed ID: 22335589
    [No Abstract]   [Full Text] [Related]  

  • 8. I double dare me.
    McCalmont TH
    J Cutan Pathol; 2012 Jan; 39(1):5-7. PubMed ID: 22211328
    [No Abstract]   [Full Text] [Related]  

  • 9. AFX: what we now know.
    McCalmont TH
    J Cutan Pathol; 2011 Nov; 38(11):853-6. PubMed ID: 21955311
    [No Abstract]   [Full Text] [Related]  

  • 10. Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
    Ellis R; Chase E; Barland A; Rajpara A; Fraga GR
    J Cutan Pathol; 2015 Nov; 42(11):847-52. PubMed ID: 26041010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle cell neoplasms.
    Beck EM; Bauman TM; Rosman IS
    J Cutan Pathol; 2018 Aug; 45(8):581-587. PubMed ID: 29687929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
    Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
    Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
    Sigal AC; Keenan M; Lazova R
    Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
    Miller K; Goodlad JR; Brenn T
    Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fibroxanthoma.
    Weedon D; Van Deurse M
    J Cutan Pathol; 2012 May; 39(5):565. PubMed ID: 22443422
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices in diagnostic immunohistochemistry: spindle cell neoplasms of the gastrointestinal tract.
    Turner MS; Goldsmith JD
    Arch Pathol Lab Med; 2009 Sep; 133(9):1370-4. PubMed ID: 19722741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
    Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
    Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
    Tran TAN; Linos K; de Abreu FB; Carlson JA
    Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.